Digital clinics for diagnosing and treating migraine

Author:

Nyberg Johan1ORCID,Rosenbacke Rikard2,Ben-Menachem Elinor3

Affiliation:

1. Stortorgets neurologmottagning, Helsingborg, Sweden

2. Centre for Corporate Governance, Department of Accounting, Copenhagen Business School, Copenhagen, Denmark

3. Department of Clinical Neuroscience, Institute of Neuroscience and Physiology, University of Gothenburg, Sweden

Abstract

Purpose of review Several innovative digital technologies have begun to be applied to diagnosing and treating migraine. We reviewed the potential benefits and opportunities from delivering migraine care through comprehensive digital clinics. Recent findings There are increasing applications of digitization to migraine diagnosis and management, including e-diaries, and patient self-management, especially after the COVID-19 pandemic. Digital care delivery appears to better engage chronic migraine sufferers who may struggle to present to physical clinics. Summary Digital clinics appear to be a promising treatment modality for patients with chronic migraine. They potentially minimize travel time, shorten waiting periods, improve usability, and increase access to neurologists. Additionally, they have the potential to provide care at a much lower cost than traditional physical clinics. However, the current state of evidence mostly draws on case-reports, suggesting a need for future randomized trials comparing digital interventions with standard care pathways.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Reference30 articles.

1. Global, regional and national burden of neurological disorders during 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015;Lancet Neurol,2015

2. Migraine remains second among the world’s causes of disability, and first among young women: findings from GBD2019;Steiner;J Headache Pain,2020

3. Burden and cost of migraine in a Swedish defined patient population—a questionnaire-based study;Hjalte;J Headache Pain,2019

4. Emerging drugs for the preventive treatment of migraine: a review of CGRP monoclonal antibodies and gepants trials;Silvestro;Expert Opin Emerg Drugs,2023

5. Integrated care for chronic migraine patients: epidemiology, burden, diagnosis and treatment options;Diener;Clin Med (Lond),2015

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3